Cost-of-illness studies: concepts, scopes, and methods
C. Jo
|
9 |
2014 |
9
2014
|
Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
Seung-Hoi Koo
|
8 |
2013 |
8
2013
|
Global incidence and prevalence of nonalcoholic fatty liver disease
9 auth.
Margaret Teng,
C. Ng,
Daniel Q. Huang,
K. Chan,
Darren J. H. Tan,
W. Lim,
...
J. D. Yang,
E. Tan,
M. Muthiah
|
8 |
2022 |
8
2022
|
KASL Clinical Practice Guidelines: Management of chronic hepatitis B
B. Yoo,
H. Yim
|
8 |
2012 |
8
2012
|
A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
S. Yu
|
8 |
2016 |
8
2016
|
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
20 auth.
S. Kang,
H. Lee,
Jeong-Ju Yoo,
Yuri Cho,
Seung-Up Kim,
Tae Hee Lee,
B. Jang,
Sang Gyune Kim,
S. Ahn,
Haeryoung Kim,
...
D. Jun,
Joon-Il Choi,
D. Song,
Won Kim,
S. Jeong,
M. Kim,
H. Koh,
Sujin Jeong,
Jin-Woo Lee,
Y. Cho
|
7 |
2021 |
7
2021
|
MAFLD: How is it different from NAFLD?
Cameron Gofton,
Yadhavan Upendran,
M. Zheng,
J. George
|
7 |
2022 |
7
2022
|
Genetic predisposition in nonalcoholic fatty liver disease
S. Sookoian,
C. Pirola
|
7 |
2017 |
7
2017
|
Hepatitis C virus: virology and life cycle
C. Kim,
Kyong‐Mi Chang
|
7 |
2013 |
7
2013
|
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
Tae-Hyung Kim,
S. Kim,
A. Tang,
J. Lee
|
7 |
2019 |
7
2019
|
Epidemiology of liver cancer in South Korea
B. Kim,
Joong-Won Park
|
7 |
2017 |
7
2017
|
Hepatitis C virus-induced hepatocellular carcinoma
N. Goossens,
Y. Hoshida
|
7 |
2015 |
7
2015
|
Drug-induced liver injury: present and future
K. Suk,
D. J. Kim
|
7 |
2012 |
7
2012
|
Hepatic venous pressure gradient: clinical use in chronic liver disease
K. Suk
|
7 |
2014 |
7
2014
|
